Chargement en cours...
Ovarian Cancer Immunotherapy and Personalized Medicine
Ovarian cancer response to immunotherapy is limited; however, the evaluation of sensitive/resistant target treatment subpopulations based on stratification by tumor biomarkers may improve the predictiveness of response to immunotherapy. These markers include tumor mutation burden, PD-L1, tumor-infil...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8234871/ https://ncbi.nlm.nih.gov/pubmed/34207103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22126532 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|